cobalt has been researched along with fasudil in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Agrawal, SK; Barnes, R; Kesherwani, V; Tarang, S | 1 |
Ahn, HY; Choi, M; Joe, YA; Kim, HK; Kim, KS; Lee, HS; Lim, HS; Shin, JC | 1 |
2 other study(ies) available for cobalt and fasudil
Article | Year |
---|---|
Fasudil reduces GFAP expression after hypoxic injury.
Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Animals; Astrocytes; Cell Hypoxia; Cell Line, Tumor; Cobalt; Glial Fibrillary Acidic Protein; Gliosis; Humans; Male; Rats, Wistar; Reperfusion Injury; rho-Associated Kinases; Spinal Cord | 2014 |
Priming Wharton's jelly-derived mesenchymal stromal/stem cells with ROCK inhibitor improves recovery in an intracerebral hemorrhage model.
Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Animals; Blotting, Western; Cell Differentiation; Cells, Cultured; Cerebral Hemorrhage; Cobalt; Disease Models, Animal; Gene Expression; Glial Cell Line-Derived Neurotrophic Factor; Humans; Male; Mesenchymal Stem Cell Transplantation; Mesenchymal Stem Cells; Microscopy, Confocal; Neurons; Protein Kinase Inhibitors; Rats, Sprague-Dawley; Recovery of Function; Reverse Transcriptase Polymerase Chain Reaction; rho-Associated Kinases; Wharton Jelly | 2015 |